" class="no-js "lang="en-US"> Norman Law - Medtech Alert
Tuesday, November 05, 2024
Norman Law

Norman Law

About Norman Law

Experienced leader in biotech IP, skilled in patent law, technology evaluation and competitive intelligence. Also Head of IP at Adaptimmune ($ADAP). Pharmacologist with 28 years industry experience who has taken two drugs from bench to market at TopoTarget (now Onxeo), research training at Yale and Cornell.

Related Story

MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases

April 25 2022

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest […]